Neurogene Inc Stock Performance
as on May 8, 2026 at 1:04 am IST
Day's Low
Day's High
$31.78$33.53
3.40%
Downside
1.91%
Upside
52 Week's Low
52 Week's High
$12.97$37.2760.58%
Downside
13.27%
Upside
Neurogene Inc share price movements today
- Previous Close
- $32.33
- Open
- $32.29
- Volume
- 24.6K
- Day's Low - High
- $31.78 - $33.53
- 52 Week Low - High
- $12.97 - $37.27
Neurogene Inc Historical Returns
- 1 Month Return
- + 54.62 %
- 3 Month Return
- + 87.64 %
- 1 Year Return
- + 133.26 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Neurogene Inc Stock Fundamentals & Key Indicators
Check Neurogene Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$451.9M
EPS (TTM)
-5.0017
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-100.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-31.41%
Neurogene Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neurogene Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $451.9M | NA | NA | 0.00% | |
| BUY | $40.5B | 130.77% | 76.32 | 12.55% | |
| BUY | $108.5B | 98.9% | 25.38 | 35.51% | |
| NA | $32.5B | NA | 70.89 | 5.37% | |
| BUY | $75.6B | 45.15% | 17.6 | 29.65% |
Stock Returns calculator for Neurogene Inc Stock including INR - Dollar returns
The Neurogene Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Neurogene Inc investment value today
Current value as on today
₹2,64,043
Returns
₹1,64,043
(+164.04%)
Returns from Neurogene Inc Stock
₹1,37,374 (+137.37%)
Dollar Impact
₹26,669 (+26.67%)
Analyst Recommendation on Neurogene Inc Stock
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Neurogene Inc. Average target price of $76.43
Neurogene Inc Share Price Target
Get share price movements and forecasts by analysts on Neurogene Inc.
What analysts predicted
56.95%UPSIDE
Target Price
$76.43
Current Price
$32.9
Analyzed by
11 Analysts
Target
$76.43
Neurogene Inc target price $76.43, a slight upside of 56.95% compared to current price of $32.9. According to 11 analysts rating.
Indian Investors' Interest in Neurogene Inc Stock
Search interest for Neurogene Inc Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:10% versus previous 30 day period
Neurogene Inc Quarterly Profit & Loss
All numbers in Millions USD
Neurogene Inc Annual Profit & Loss
All numbers in Millions USD
Neurogene Inc Quarterly Cash Flow
All numbers in Millions USD
Neurogene Inc Annual Cash Flow
All numbers in Millions USD
Insights on Neurogene Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, NGNE has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, NGNE has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, NGNE stock has moved up by 23.9%
About Neurogene Inc
| Organisation | Neurogene Inc |
| Headquarters | 535 W 24th Street, New York, NY, United States, 10011 |
| Industry | Biotechnology |
| CEO | Dr. Rachel L. McMinn Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Neurogene Inc
Name | Title |
|---|---|
Ms. Christine Mikail Cvijic J.D. | President, CFO & Director |
Dr. Stuart Cobb Ph.D. | Chief Scientific Officer |
Dr. Andrew E. Mulberg CPI, FAAP, M.D. | Senior VP of Regulatory Affairs, Quality Assurance & Quality Control |
Ms. Christina Shafer | Chief Commercial Officer |
Mr. Arvind Sreedharan | Senior Vice President of Business Operations |
Dr. Rachel L. McMinn Ph.D. | Founder, Executive Chair & CEO |
Dr. Julie Jordan M.D. | Chief Medical Officer |
Ms. Donna M. Cochener-Metcalfe J.D., L.L.M. | Senior VP, General Counsel & Corporate Secretary |
Mr. Ricardo Jimenez | Senior Vice President of Technical Operations |
FAQs
What is Neurogene Inc share price today?
Neurogene Inc share price today is $32.9 as on . Neurogene Inc share today touched a day high of $33.53 and a low of $31.78.
What is the 52 week high and 52 week low for Neurogene Inc share?
Neurogene Inc share touched a 52 week high of $37.27 on and a 52 week low of $12.97 on . Neurogene Inc stock price today i.e. is trending at $32.9,which is 11.72% down from its 52 week high and 153.66% up from its 52 week low.
What is Neurogene Inc's market capitalisation today?
Neurogene Inc market capitalisation is $0.00T as on .
How to invest in Neurogene Inc Stock (NGNE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neurogene Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurogene Inc Shares that will get you 0.0456 shares as per Neurogene Inc share price of $32.9 per share as on May 7, 2026 at 7:34 pm IST.
What is the minimum amount required to buy Neurogene Inc Stock (NGNE) from India?
Indian investors can start investing in Neurogene Inc (NGNE) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Neurogene Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neurogene Inc share’s latest price of $32.9 as on May 7, 2026 at 7:34 pm IST, you will get 0.3040 shares of Neurogene Inc. Learn more about
fractional shares .